Login
Super Investors PURA VIDA INVESTMENTS, LLC
PV

PURA VIDA INVESTMENTS, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$37M
Positions
19
Quarter ended
June 30, 2026
Filed
August 13, 2026

Reported portfolio value by quarter (47 quarters reported)

$3.51B $13.7M
Q4 14 Q2 17 Q4 19 Q2 22 Q4 24 Q2 26

$272M in Q4 2014 → $37M now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Alamar Biosciences Inc 55.4% New 755,909 $20.5M
Beta Bionics Inc 11.9% Trimmed 0.0% 281,164 $4.41M
EL Establishment Labs Hldgs Inc 10.4% Unchanged 45,000 $3.86M
IM Insight Molecular Dia Inc 7.7% Trimmed 49% 484,845 $2.86M
Nvidia Corporation 1.2% Trimmed 8.0% 2,300 $460K
Caris Life Sciences Inc 1.2% Trimmed 72% 25,500 $454K
Jpmorgan Chase & Co 1.2% Unchanged 1,350 $442K
Alphabet Inc 1.1% Added 0.8% 1,200 $424K
Natera Inc 1.1% Trimmed 40% 1,500 $407K
Analog Devices Inc 1.1% Unchanged 1,000 $397K
AH Asml Hldg Nv 1.0% Unchanged 190 $378K
Microsoft Corp 1.0% Added 1.0% 1,000 $373K
OM Outset Med Inc 1.0% Unchanged 83,333 $360K
Apple Inc 0.9% Unchanged 1,165 $337K
Inspiremd Inc 0.9% Unchanged 450,517 $315K
Metagenomi Therapeutics Inc 0.9% Unchanged 264,391 $315K
Amazon Com Inc 0.7% Unchanged 1,100 $262K
Linde PLC 0.7% Unchanged 500 $259K
Coca Cola Co 0.5% New 2,500 $203K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q2 2026

quarter ended June 30, 2026 · filed August 13, 2026

Company Action Shares changed Value of change % of portfolio
Alamar Biosciences Inc New +755,909 +$20.5M 55.4%
IM Insight Molecular Dia Inc Trimmed −462,289 −$2.73M 7.7%
Caris Life Sciences Inc Trimmed −64,440 −$1.15M 1.2%
Natera Inc Trimmed −1,000 −$271K 1.1%
Coca Cola Co New +2,500 +$203K 0.5%
Nvidia Corporation Trimmed −200 −$40K 1.2%
Microsoft Corp Added +10 +$3.73K 1.0%
Alphabet Inc Added +10 +$3.53K 1.1%
Beta Bionics Inc Trimmed −86 −$1.35K 11.9%

Q1 2026

quarter ended March 31, 2026 · filed May 12, 2026

Company Action Shares changed Value of change % of portfolio
OM Outset Med Inc Added +78,333 +$301K 2.2%
Danaher Corporation Exited −900 −$206K —
Microsoft Corp Trimmed −210 −$77.7K 2.5%
Nvidia Corporation Added +170 +$29.6K 2.9%
Amazon Com Inc Added +100 +$20.8K 1.5%

Q4 2025

quarter ended December 31, 2025 · filed February 13, 2026

Company Action Shares changed Value of change % of portfolio
Microsoft Corp New +1,200 +$580K 2.2%
Jpmorgan Chase & Co. New +1,350 +$435K 1.6%
Nvidia Corporation New +2,330 +$435K 1.6%
Alphabet Inc New +1,190 +$373K 1.4%
Apple Inc New +1,165 +$317K 1.2%
Analog Devices Inc New +1,000 +$271K 1.0%
Amazon Com Inc New +1,000 +$231K 0.9%
Linde PLC New +500 +$213K 0.8%
Danaher Corporation New +900 +$206K 0.8%
AH Asml Holding N V New +190 +$203K 0.8%

Q3 2025

quarter ended September 30, 2025 · filed November 12, 2025

Company Action Shares changed Value of change % of portfolio
OM Outset Med Inc Trimmed −424,120 −$84.8M 6.1%
Natera Inc Trimmed −243,191 −$39.1M 2.5%
Beta Bionics Inc Added +278,750 +$5.54M 34.0%
IM Insight Molecular Dia Inc Added +928,434 +$3.08M 19.2%
EL Establishment Labs Hldgs Inc Trimmed −44,940 −$1.84M 11.2%
M Metagenomi Inc Trimmed −687,743 −$1.63M 3.8%
Caris Life Sciences Inc Added +44,940 +$1.36M 16.6%

Q2 2025

quarter ended June 30, 2025 · filed August 13, 2025

Company Action Shares changed Value of change % of portfolio
Beta Bionics Inc Trimmed −426,620 −$1.07B 37.6%
IM Insight Molecular Dia Inc Trimmed −928,434 −$142M 17.2%
Caris Life Sciences Inc New +45,000 +$2.4M 14.5%
OM Outset Med Inc Added +424,120 +$1.34M 8.2%
KM Kestra Med Technologies Ltd Exited −40,000 −$997K —
EL Establishment Labs Hldgs Inc Added +44,940 +$960K 11.6%
Natera Inc Added +243,191 +$418K 2.5%
M Metagenomi Inc Added +687,743 +$283K 2.4%

Q1 2025

quarter ended March 31, 2025 · filed May 12, 2025

Company Action Shares changed Value of change % of portfolio
Beta Bionics Inc New +429,120 +$5.25M 38.4%
AT Advisorshares Tr Exited −750,000 −$2.86M —
EL Establishment Labs Hldgs Inc Trimmed −68,041 −$2.78M 13.4%
Pulmonx Corp Exited −387,200 −$2.63M —
Quanterix Corp Exited −234,755 −$2.5M —
Intuitive Surgical Inc Exited −3,500 −$1.83M —
Glaukos Corp Exited −12,000 −$1.8M —
VE Vaneck ETF Trust Exited −20,000 −$1.73M —
Natera Inc Exited −10,000 −$1.58M —
Bioventus Inc Exited −150,000 −$1.58M —

Showing the 10 largest of 20 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 12, 2025

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr Exited −40,000 −$8.84M —
SS SPDR S&P 500 ETF Tr Exited −15,000 −$8.61M —
IT Ishares Tr Trimmed −130,000 −$7.59M 3.7%
IQ Invesco Qqq Tr Exited −15,000 −$7.32M —
CC Cooper Cos Inc Exited −60,000 −$6.62M —
IM Inspire Med Sys Inc Exited −30,000 −$6.33M —
Waters Corp Exited −17,500 −$6.3M —
Natera Inc Trimmed −38,500 −$6.09M 2.5%
Glaukos Corp Exited −44,000 −$5.73M —
Intuitive Surgical Inc Exited −10,200 −$5.01M —

Showing the 10 largest of 47 changes.

Q3 2024

quarter ended September 30, 2024 · filed November 14, 2024

Company Action Shares changed Value of change % of portfolio
IT Ishares Tr New +150,000 +$8.88M 5.8%
IT Ishares Tr New +40,000 +$8.84M 5.8%
IM Inspire Med Sys Inc New +30,000 +$6.33M 4.1%
Waters Corp New +17,500 +$6.3M 4.1%
AT Advisorshares Tr Added +836,100 +$5.99M 7.6%
SS SPDR S&P 500 ETF Tr Trimmed −10,000 −$5.74M 5.6%
Masimo Corp Exited −44,500 −$5.6M —
Glaukos Corp Trimmed −43,000 −$5.6M 3.7%
IT Ishares Tr Exited −90,000 −$5.04M —
SS SPDR Ser Tr New +50,000 +$4.94M 3.2%

Showing the 10 largest of 61 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support